Page last updated: 2024-09-05

phosphatidylcholines and Opportunistic Infections

phosphatidylcholines has been researched along with Opportunistic Infections in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (11.11)18.2507
2000's8 (88.89)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Demir, M; Kaldir, M; Turgut, B; Vural, O1
Brio, S; Cantón, E; Carrillo-Muñoz, AJ; del Valle, O; Guarro, J; Hernández-Molina, JM; Pemán, J; Quindós, G; Rodriguez, V; Ruesga, M; Santos, P1
Brugère, JF; Grillot, R; Kazemi, A; Noodeh, AD; Robson, G; Shen, DK1
Chandrasekar, PH; Ito, JI1
Perfect, JR1
Baddour, LM; Ostrosky-Zeichner, L; Perfect, JR1
Chandrasekar, PH; Hooshmand-Rad, R; Ito, JI1
Chopra, R; Clark, AD; Franklin, IM; McKendrick, S; Tansey, PJ1
Ali, LI; Carter, TH; Roy, V; Selby, GB1

Other Studies

9 other study(ies) available for phosphatidylcholines and Opportunistic Infections

ArticleYear
Candida arthritis in a patient with chronic myelogenous leukemia (CML) in blastic transformation, unresponsive to fluconazole, but treated effectively with liposomal amphotericin B.
    Annals of hematology, 2002, Volume: 81, Issue:9

    Topics: Amphotericin B; Arthritis, Infectious; Blast Crisis; Candidiasis; Drug Combinations; Drug Resistance; Fatal Outcome; Female; Fluconazole; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Middle Aged; Opportunistic Infections; Phosphatidylcholines; Phosphatidylglycerols

2002
Comparison of in vitro antifungal activities of amphotericin B lipid complex with itraconazole against 708 clinical yeast isolates and opportunistic moulds determined by National Committee for Clinical Laboratory Standards methods M27-A and M38-P.
    Chemotherapy, 2002, Volume: 48, Issue:5

    Topics: Amphotericin B; Antifungal Agents; Culture Media; Dose-Response Relationship, Drug; Drug Combinations; Drug Resistance, Fungal; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Opportunistic Infections; Phosphatidylcholines; Phosphatidylglycerols; Quality Control; Yeasts

2002
Characterisation and expression of phospholipases B from the opportunistic fungus Aspergillus fumigatus.
    FEMS microbiology letters, 2004, Oct-01, Volume: 239, Issue:1

    Topics: Amino Acid Sequence; Aspergillus fumigatus; Bacterial Proteins; DNA, Complementary; Gene Expression Regulation, Fungal; Humans; Lysophospholipase; Molecular Sequence Data; Opportunistic Infections; Phosphatidylcholines; Sequence Analysis, DNA; Up-Regulation

2004
Amphotericin B lipid complex in the management of invasive aspergillosis in immunocompromised patients.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, May-01, Volume: 40 Suppl 6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Aspergillosis; Child; Child, Preschool; Drug Combinations; Female; Humans; Immunocompromised Host; Infant; Male; Middle Aged; Opportunistic Infections; Phosphatidylcholines; Phosphatidylglycerols; Registries; Treatment Outcome

2005
Treatment of non-Aspergillus moulds in immunocompromised patients, with amphotericin B lipid complex.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, May-01, Volume: 40 Suppl 6

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Child; Child, Preschool; Drug Combinations; Female; Fusarium; Humans; Immunocompromised Host; Infant; Kidney; Male; Middle Aged; Mycoses; Opportunistic Infections; Phosphatidylcholines; Phosphatidylglycerols; Registries; Retrospective Studies; Treatment Outcome; Zygomycosis

2005
Successful use of amphotericin B lipid complex in the treatment of cryptococcosis.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2005, May-01, Volume: 40 Suppl 6

    Topics: Adult; Amphotericin B; Antifungal Agents; Cryptococcosis; Drug Combinations; Female; Humans; Immunocompromised Host; Male; Opportunistic Infections; Phosphatidylcholines; Phosphatidylglycerols; Registries; Treatment Outcome

2005
Effectiveness of amphotericin B lipid complex (ABLC) treatment in allogeneic hematopoietic cell transplant (HCT) recipients with invasive aspergillosis (IA).
    Bone marrow transplantation, 2005, Volume: 36, Issue:10

    Topics: Adolescent; Adult; Aged; Amphotericin B; Aspergillosis; Child; Child, Preschool; Databases, Factual; Drug Combinations; Drug Evaluation; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppression Therapy; Lung Diseases, Fungal; Male; Middle Aged; Opportunistic Infections; Phosphatidylcholines; Phosphatidylglycerols; Retrospective Studies; Transplantation, Homologous; Treatment Outcome

2005
A comparative analysis of lipid-complexed and liposomal amphotericin B preparations in haematological oncology.
    British journal of haematology, 1998, Volume: 103, Issue:1

    Topics: Adult; Amphotericin B; Antifungal Agents; Creatinine; Drug Combinations; Female; Hematologic Neoplasms; Humans; Immune Tolerance; Leukocyte Count; Male; Mycoses; Neutrophils; Opportunistic Infections; Phosphatidylcholines; Phosphatidylglycerols; Retrospective Studies; Treatment Outcome; Water-Electrolyte Imbalance

1998
Successful non-surgical treatment of disseminated polymicrobial fungal infection in a patient with pancytopenia and graft-versus-host disease.
    The Journal of infection, 2000, Volume: 41, Issue:3

    Topics: Adult; Amphotericin B; Antifungal Agents; Aspergillosis; Bone Marrow Transplantation; Drug Combinations; Drug Therapy, Combination; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Itraconazole; Lymphoma, Follicular; Male; Mucormycosis; Opportunistic Infections; Pancytopenia; Phosphatidylcholines; Phosphatidylglycerols

2000